We are live on ! Find out more
TEE

Tibra Equities Europe Portfolio holdings

AUM $90.4M
1-Year Est. Return 37.81%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
10 Year Est. Return
AUM
$571M
AUM Growth
+$338M
Cap. Flow
+$344M
Cap. Flow %
60.24%
Top 10 Hldgs %
55.64%
Holding
296
New
169
Increased
12
Reduced
7
Closed
107

Top Buys

Rank Stock Value
1
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$76.4M
2
MSFT icon
Microsoft
MSFT
+$36.1M
3
BA icon
Boeing
BA
+$29.1M
4
MCD icon
McDonald's
MCD
+$26.5M
5
JNJ icon
Johnson & Johnson
JNJ
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 14.72%
2 Healthcare 8.67%
3 Industrials 8.15%
4 Materials 6.51%
5 Consumer Staples 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADVM
101
DELISTED
Adverum Biotechnologies
ADVM
$627K 0.11%
+10,806
New +$673K
IO
102
DELISTED
ION Geophysical Corporation
IO
$627K 0.11%
+23,142
New +$549K
MNKD icon
103
MannKind Corp
MNKD
$1.32B
$608K 0.11%
+266,545
New +$718K
AXON
104
Axon Enterprise
AXON
$46.4B
$603K 0.11%
+15,332
New +$478K
BXC icon
105
BlueLinx
BXC
$706M
$596K 0.1%
+18,291
New +$340K
UBSI icon
106
United Bankshares
UBSI
$6.62B
$593K 0.1%
+16,825
New +$609K
XXII
107
22nd Century Group
XXII
$1.48M
0
ALBO
108
DELISTED
Albireo Pharma Inc
ALBO
$590K 0.1%
+18,101
New +$609K
GYRE icon
109
Gyre Therapeutics
GYRE
$744M
$587K 0.1%
+3,035
New +$566K
AMPE
110
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$585K 0.1%
+574
New +$481K
ZN
111
DELISTED
Zion Oil & Gas, Inc.
ZN
$576K 0.1%
+121,081
New +$420K
ASXC
112
DELISTED
Asensus Surgical, Inc.
ASXC
$570K 0.1%
+25,813
New +$591K
PACW
113
DELISTED
PacWest Bancorp
PACW
$553K 0.1%
+11,169
New +$583K
ABM icon
114
ABM Industries
ABM
$2.84B
$547K 0.1%
+16,334
New +$598K
SENS icon
115
Senseonics Holdings Inc
SENS
$366M
$546K 0.1%
+9,100
New +$524K
NES
116
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$535K 0.09%
+23,121
New +$476K
ARQL
117
DELISTED
Arqule Inc
ARQL
$530K 0.09%
+184,014
New +$349K
CYRX icon
118
CryoPort
CYRX
$762M
$521K 0.09%
+60,534
New +$535K
RBBN icon
119
Ribbon Communications
RBBN
$383M
$512K 0.09%
+100,410
New +$650K
QHC
120
DELISTED
Quorum Health Corporation
QHC
$509K 0.09%
+62,238
New +$408K
SBS icon
121
Sabesp
SBS
$18.7B
$493K 0.09%
+240,041
New +$516K
FRBA icon
122
First Bank
FRBA
$454M
$492K 0.09%
+34,201
New +$481K
CBMG
123
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$487K 0.09%
+27,777
New +$508K
AOI
124
DELISTED
Alliance One International
AOI
$479K 0.08%
+18,379
New +$346K
CTIC
125
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$479K 0.08%
+122,760
New +$432K

Similar funds

Tibra Equities Europe's Q1 2018 Portfolio in Review

As of Q1 2018, Tibra Equities Europe held 296 positions worth $571M, up 145% from $233M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Tibra Equities Europe deployed $344M of net new capital in Q1 2018, opening 169 new positions and adding to 12 existing holdings. Its largest new stake was iShares MSCI Saudi Arabia ETF: 2,780,245 shares worth $81.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iShares Russell 1000 ETF, an estimated $8.44M trimmed.

  • Tibra Equities Europe's largest Q1 2018 buy was iShares MSCI Saudi Arabia ETF: 2,780,245 shares worth $81.4M.
  • Tibra Equities Europe added most to State Street Consumer Staples Select Sector SPDR ETF in Q1 2018, an estimated $17.9M increase.
  • Tibra Equities Europe's biggest Q1 2018 reduction was iShares Russell 1000 ETF, cutting an estimated $8.44M.
  • Tibra Equities Europe fully exited iShares Biotechnology ETF in Q1 2018, selling an estimated $22.9M.
  • Tibra Equities Europe's ten largest holdings make up 56% of its $571M portfolio in Q1 2018.
  • Tibra Equities Europe opened 169 new positions and closed 107 in Q1 2018.
  • Tibra Equities Europe's portfolio value rose 145% quarter-over-quarter to $571M.

Based on Tibra Equities Europe's 13F filing for Q1 2018, filed 11 May 2018.